On page 3 of the announcement underneath the graphic showing the dose escalations it states "Further dose escalation to continue as long as no safety issues are observed". How do you interpret that statement? The IT monotherapy does has reached the top of the card and the only does that looks like it can increase is the IT + Pembro combination.
I wonder if it is just that cohort being referred to or if they are indeed planning to continue dosing higher amounts past what is described in the graphic.
Ann: Bile Tract Cancer Study Opens after MAST High Dose Clearance, page-67
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.1¢ |
Change
-0.002(3.77%) |
Mkt cap ! $373.3M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.2¢ | 5.0¢ | $669.7K | 13.07M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1074997 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.2¢ | 1209633 | 6 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |